Rare Community Profiles: Heart Attack at 27: How an HoFH Diagnosis Allowed Peter to Live a More Empowered Life
source: shutterstock.com

Rare Community Profiles: Heart Attack at 27: How an HoFH Diagnosis Allowed Peter to Live a More Empowered Life

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: Heart Attack at 27: How an HoFH Diagnosis Allowed Peter to Live a More Empowered Life
This Company Just Withdrew Two of Its Drug Approvals for Mantle Cell Lymphoma and Marginal Zone Lymphoma
source: shutterstock.com

This Company Just Withdrew Two of Its Drug Approvals for Mantle Cell Lymphoma and Marginal Zone Lymphoma

According to a story from BioPharma Dive, the drug company AbbVie has recently announced its decision to withdraw two different approvals for its cancer therapy Imbruvica. The approvals were withdrawn…

Continue Reading This Company Just Withdrew Two of Its Drug Approvals for Mantle Cell Lymphoma and Marginal Zone Lymphoma
Rare Community Profiles: Study Investigator Dr. Weyand Discusses the Trial Data that Led to ALTUVIIIO Approval for Hemophilia A
source: shutterstock.com

Rare Community Profiles: Study Investigator Dr. Weyand Discusses the Trial Data that Led to ALTUVIIIO Approval for Hemophilia A

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: Study Investigator Dr. Weyand Discusses the Trial Data that Led to ALTUVIIIO Approval for Hemophilia A
Study of the Week: Niemann-Pick Disease Type C Biomarker Could Help Diagnose Congenital Disorders of Glycosylation
source: pixabay.com

Study of the Week: Niemann-Pick Disease Type C Biomarker Could Help Diagnose Congenital Disorders of Glycosylation

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Niemann-Pick Disease Type C Biomarker Could Help Diagnose Congenital Disorders of Glycosylation
A New National Analysis Indicates that Higher Levels of Black Primary Care Physicians Means Longer Life Expectancy for Black Patients
source: shutterstock.com

A New National Analysis Indicates that Higher Levels of Black Primary Care Physicians Means Longer Life Expectancy for Black Patients

  Over the years, there has been minimal improvement in the life expectancy differences between white and black people living in the United States. Yet, according to an article featured…

Continue Reading A New National Analysis Indicates that Higher Levels of Black Primary Care Physicians Means Longer Life Expectancy for Black Patients
Amyotrophic Lateral Sclerosis Drug Developers Set Their Sights on a New Treatment Target
source: pixabay.com

Amyotrophic Lateral Sclerosis Drug Developers Set Their Sights on a New Treatment Target

On March 22, 2023, via PRNewswire, the FDA announced that its CNS Drugs Advisory Committee voted unanimously in favor of a potential accelerated approval of tofersen to treat people with…

Continue Reading Amyotrophic Lateral Sclerosis Drug Developers Set Their Sights on a New Treatment Target
Draft Guidance from the FDA Suggests Important Changes to Drug Development
source: shutterstock.com

Draft Guidance from the FDA Suggests Important Changes to Drug Development

On February 1, 2023, FDA issued a Draft Guidance Document, called “Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products” (Docket ID: FDA-2022-D-2983).  The Draft Guidance considers…

Continue Reading Draft Guidance from the FDA Suggests Important Changes to Drug Development

For Patients Under Consideration for CAR-T Therapy The Cancer Support Community/Gilda’s Club Has A Free Program

No One Should Face Cancer Alone. That is the mission of the non-profit Cancer Support Community (CSC). It offers emotional support and hope via programs designed for cancer patients, cancer…

Continue Reading For Patients Under Consideration for CAR-T Therapy The Cancer Support Community/Gilda’s Club Has A Free Program
Research!America Discussion with Dr. Mary Pittman: Better Data for More Equitable Research
source: shutterstock.com

Research!America Discussion with Dr. Mary Pittman: Better Data for More Equitable Research

On April 12, 2023, Research!America, a Patient Worthy partner organization, hosted a webinar program titled Better Data for More Equitable Public Health Research. This talk featured Dr. Mary Pittman, President…

Continue Reading Research!America Discussion with Dr. Mary Pittman: Better Data for More Equitable Research
Rare Community Profiles: How Stephanie’s Desmoid Tumor Journey Inspired Her Fight Against Medical Gaslighting
source: shutterstock.com

Rare Community Profiles: How Stephanie’s Desmoid Tumor Journey Inspired Her Fight Against Medical Gaslighting

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: How Stephanie’s Desmoid Tumor Journey Inspired Her Fight Against Medical Gaslighting
The Chan Zuckerberg Initiative is Providing Financial Support for Patient-Centered Rare Disease Research
source: pixabay.com

The Chan Zuckerberg Initiative is Providing Financial Support for Patient-Centered Rare Disease Research

 In 2003 Ricky Safer was diagnosed with primary sclerosing cholangitis (PSC). Her doctors were not able to tell her much about the origin of her disease. Nor were they able…

Continue Reading The Chan Zuckerberg Initiative is Providing Financial Support for Patient-Centered Rare Disease Research
Students Cheer on Peer with Chromosome 2q24 Microdeletion Syndrome as He Heads to a Special Olympics Competition
https://pixabay.com/en/board-school-task-auto-task-928392/

Students Cheer on Peer with Chromosome 2q24 Microdeletion Syndrome as He Heads to a Special Olympics Competition

When Alexander Barron (9) was first born, doctors told his parents that he would likely never walk. In fact, said doctors, Alexander would probably not be very independent at all…

Continue Reading Students Cheer on Peer with Chromosome 2q24 Microdeletion Syndrome as He Heads to a Special Olympics Competition